Compare CHMG & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHMG | MASS |
|---|---|---|
| Founded | 1833 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.1M | 251.9M |
| IPO Year | 1995 | 2020 |
| Metric | CHMG | MASS |
|---|---|---|
| Price | $66.29 | $6.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $57.00 | $12.00 |
| AVG Volume (30 Days) | 6.5K | ★ 226.3K |
| Earning Date | 04-17-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ 3.14 | 0.54 |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $37.32 | $19.44 |
| Revenue Next Year | $9.13 | $18.63 |
| P/E Ratio | $21.39 | ★ $12.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $44.76 | $4.20 |
| 52 Week High | $70.83 | $9.34 |
| Indicator | CHMG | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 71.02 | 50.63 |
| Support Level | $51.25 | $5.86 |
| Resistance Level | $70.83 | $7.48 |
| Average True Range (ATR) | 2.77 | 0.37 |
| MACD | 0.28 | -0.07 |
| Stochastic Oscillator | 76.56 | 28.63 |
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.